Consensus Molecular Subtypes (CMS) in CRC Patients

Jeffrey A. Meyerhardt, MD of Dana Farber Cancer Institute discusses the four consensus molecular subtypes and how they help with the therapeutic decision making for patients with colorectal cancer at... Author: obr Added: 01/23/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts